Search details
1.
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 650-658, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35421369
2.
Nivolumab versus placebo in patients with relapsed malignant mesothelioma (CONFIRM): a multicentre, double-blind, randomised, phase 3 trial.
Lancet Oncol
; 22(11): 1530-1540, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34656227
3.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med
; 377(4): 338-351, 2017 07 27.
Article
in English
| MEDLINE | ID: mdl-28578639
4.
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Lancet
; 392(10162): 2353-2366, 2018 12 01.
Article
in English
| MEDLINE | ID: mdl-30355464
5.
Performance status agreement assessed by the patient and clinician in a rapid access lung cancer service: Can either predict completion of treatment?
Eur J Cancer Care (Engl)
; 28(3): e13004, 2019 May.
Article
in English
| MEDLINE | ID: mdl-30761639
6.
Effect of Single-Fraction vs Multifraction Radiotherapy on Ambulatory Status Among Patients With Spinal Canal Compression From Metastatic Cancer: The SCORAD Randomized Clinical Trial.
JAMA
; 322(21): 2084-2094, 2019 12 03.
Article
in English
| MEDLINE | ID: mdl-31794625
7.
The value of physical performance measurements alongside assessment of sarcopenia in predicting receipt and completion of planned treatment in non-small cell lung cancer: an observational exploratory study.
Support Care Cancer
; 26(1): 119-127, 2018 01.
Article
in English
| MEDLINE | ID: mdl-28721555
8.
Palliative radiotherapy regimens for patients with thoracic symptoms from non-small cell lung cancer.
Cochrane Database Syst Rev
; 1: CD002143, 2015 Jan 14.
Article
in English
| MEDLINE | ID: mdl-25586198
9.
Prognostic factors for survival and ambulatory status at 8 weeks with metastatic spinal cord compression in the SCORAD randomised trial.
Radiother Oncol
; 173: 77-83, 2022 08.
Article
in English
| MEDLINE | ID: mdl-35618101
10.
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data.
PLoS One
; 17(6): e0269192, 2022.
Article
in English
| MEDLINE | ID: mdl-35653395
11.
Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Clash of the Generations.
Clin Lung Cancer
; 21(3): e216-e228, 2020 05.
Article
in English
| MEDLINE | ID: mdl-32014348
12.
Accelerated, Dose escalated, Sequential Chemoradiotherapy in Non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study.
BMJ Open
; 9(1): e019903, 2019 01 29.
Article
in English
| MEDLINE | ID: mdl-30700475
13.
A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma - the SKOPOS trial.
Oncoimmunology
; 7(12): e1457597, 2018.
Article
in English
| MEDLINE | ID: mdl-30524880
14.
Prostaglandin E2-mediated adenosinergic effects on CD14+ cells: Self-amplifying immunosuppression in cancer.
Oncoimmunology
; 6(2): e1268308, 2017.
Article
in English
| MEDLINE | ID: mdl-28344879
15.
The burden of neutropenic sepsis in patients with advanced non-small cell lung cancer treated with single-agent docetaxel: A retrospective study.
Lung Cancer
; 113: 115-120, 2017 11.
Article
in English
| MEDLINE | ID: mdl-29110837
16.
Cardiovascular effects of hormone therapy for prostate cancer.
Drug Healthc Patient Saf
; 7: 129-38, 2015.
Article
in English
| MEDLINE | ID: mdl-26229507
17.
Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).
Eur Urol
; 67(6): 1028-1038, 2015 Jun.
Article
in English
| MEDLINE | ID: mdl-25301760
18.
CT-planned accelerated hypofractionated radiotherapy in the radical treatment of non-small cell lung cancer.
Lung Cancer
; 45(2): 237-42, 2004 Aug.
Article
in English
| MEDLINE | ID: mdl-15246196
19.
Optimizing collimator margins for isotoxically dose-escalated conformal radiation therapy of non-small cell lung cancer.
Int J Radiat Oncol Biol Phys
; 88(5): 1148-53, 2014 Apr 01.
Article
in English
| MEDLINE | ID: mdl-24529713
20.
Severe prolonged immunosuppression following fludarabine and rituximab combination therapy.
Chemotherapy
; 54(3): 242-4, 2008.
Article
in English
| MEDLINE | ID: mdl-18560233